The IPO price range for Pine Labs is ₹210 to ₹221.00 per share. 67 shares make up the IPO lot size. The company hopes to raise ₹3,899.91 crore from the book-building offer at the upper end of the price range.
Pine Labs IPO: Today, November 7, 2025, the merchant commerce platform Pine Labs Ltd. is launching its initial public offering (IPO) to generate about ₹3,900 crore from the primary markets. The Pine Labs IPO is scheduled to close on Tuesday, November 11.The IPO price range for Pine Labs is ₹210 to ₹221.00 per share. The minimum investment required by a retail investor is ₹14,807, and the IPO lot size is 67 shares.
At the top of the price range, the business wants to raise ₹3,899.91 crore through the book-building issue, which consists of an offer-for-sale of 8.23 crore shares totaling ₹1,819.91 crore and a new issue of 9.41 crore equity shares worth ₹2,080 crore.
According to the IPO schedule, the Pine Labs IPO will begin accepting subscriptions on November 7 and end on November 11. The tentative IPO listing date is November 14, and the IPO allotment date is probably November 12. The BSE and NSE will list Pine Labs shares.
The Pine Labs IPO registrar is Kfin Technologies Ltd., while the book running lead manager is Axis Capital Ltd.
According to the IPO schedule, the Pine Labs IPO will begin accepting subscriptions on November 7 and end on November 11. The tentative IPO listing date is November 14, and the IPO allotment date is probably November 12. The BSE and NSE will list Pine Labs shares.
The Pine Labs IPO registrar is Kfin Technologies Ltd., while the book running lead manager is Axis Capital Ltd.
Status of Pine Labs' IPO Subscription
According to NSE data available at 10:35 AM on Friday, the first day of the bidding process, 3% of the Pine Labs IPO has already been subscribed. 15% of Retail Individual Investors (RIIs) and 2% of Non Institutional Investors (NIIs) subscribed to the public offering. The issue has not yet been put up to bid by the Qualified Institutional Buyers (QIBs).
IPO GMP for Pine Labs Today
With a moderate grey market premium (GMP), Pine Labs shares are showing a respectable trend in the unlisted market. Pine Labs' IPO GMP is currently ₹12 per share, according to market experts. This indicates that Pine Labs shares are trading ₹12 over their issue price on the grey market.
According to NSE data available at 10:35 AM on Friday, the first day of the bidding process, 3% of the Pine Labs IPO has already been subscribed. 15% of Retail Individual Investors (RIIs) and 2% of Non Institutional Investors (NIIs) subscribed to the public offering. The issue has not yet been put up to bid by the Qualified Institutional Buyers (QIBs).
IPO GMP for Pine Labs Today
With a moderate grey market premium (GMP), Pine Labs shares are showing a respectable trend in the unlisted market. Pine Labs' IPO GMP is currently ₹12 per share, according to market experts. This indicates that Pine Labs shares are trading ₹12 over their issue price on the grey market.
Today's Pine Labs IPO GMP indicates that the equity shares are selling on the gray market for ₹233 each, which is 5.43% more than the IPO price of ₹221 per share.
Pine Labs IPO: Should I apply?
As of June 25, Pine Labs is a Fintech startup with a network of 9.8 lakh merchants, 716 consumer brands and businesses, and 177 financial institutions in India, Malaysia, Singapore, the United Arab Emirates, Australia, the United States, and Africa. The organization is prepared to take advantage of the approximately ₹276 trillion market opportunity by FY29P and has established enduring connections with prominent clients like HDFC Bank, Croma, LG Electronics, etc.
Pine Labs IPO: Should I apply?
As of June 25, Pine Labs is a Fintech startup with a network of 9.8 lakh merchants, 716 consumer brands and businesses, and 177 financial institutions in India, Malaysia, Singapore, the United Arab Emirates, Australia, the United States, and Africa. The organization is prepared to take advantage of the approximately ₹276 trillion market opportunity by FY29P and has established enduring connections with prominent clients like HDFC Bank, Croma, LG Electronics, etc.
The company produced a strong revenue and EBITDA CAGR of 19.3% and 538.6%, respectively, between FY23 and FY25. Additionally, the company intends to use the IPO revenues to pay down debt of ₹532 crore.
Based on post-issue capital, Pine Labs stock is selling at EV/Sales, EV/EBITDA, and EV/Adj EBITDA multiple of 8.0x, 82.8x, and 50.7x, respectively, at the top price range. During the FY23–FY25 period, Pine Labs' operations saw a turnaround with strong rise in EBITDA and adj EBITDA. We think the company is well-positioned to generate profitable growth in the future thanks to a strong business strategy, so we advise investors to subscribe to the issue with a long-term investment perspective," SBI Securities stated.
Based on post-issue capital, Pine Labs stock is selling at EV/Sales, EV/EBITDA, and EV/Adj EBITDA multiple of 8.0x, 82.8x, and 50.7x, respectively, at the top price range. During the FY23–FY25 period, Pine Labs' operations saw a turnaround with strong rise in EBITDA and adj EBITDA. We think the company is well-positioned to generate profitable growth in the future thanks to a strong business strategy, so we advise investors to subscribe to the issue with a long-term investment perspective," SBI Securities stated.
0 Comments